Franklin Resources
JSPR icon

Franklin Resources’s Jasper Therapeutics JSPR Stock Holding History

Franklin Resources’s Portfolio JSPR Stock Details JSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-534,713
Closed -$2.97M – 3198
2025
Q2 		$2.97M Hold
534,713
– – ﹤0.01% 1566
2025
Q1 		$2.3M Sell
534,713
-44,923
-8% -$299K ﹤0.01% 1637
2024
Q4 		$12.4M Hold
579,636
– – ﹤0.01% 1058
2024
Q3 		$9.61M Sell
579,636
-118,900
-17% -$2.37M ﹤0.01% 1140
2024
Q2 		$15.9M Sell
698,536
-23,538
-3% -$565K ﹤0.01% 937
2024
Q1 		$21.2M Buy
+722,074
New +$12.8M 0.01% 846
2023
Q4 		– Sell
-450,022
Closed -$3.15M – 2678
2023
Q3 		$3.15M Hold
450,022
– – ﹤0.01% 1227
2023
Q2 		$6.17M Hold
450,022
– – ﹤0.01% 1050
2023
Q1 		$8.15M Buy
+450,022
New +$8.32M ﹤0.01% 974

Other funds holding JSPR

VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
KCM
Kingdon Capital Management New York $597M AUM 51.11% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return